Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients

Osnabrugge, Ruben L J; Head, Stuart J; Genders, Tessa S S; Van Mieghem, Nicolas M; De Jaegere, Peter P T; van der Boon, Robert M A; Kerkvliet, J Marco; Kalesan, Bindu; Bogers, Ad J J C; Kappetein, A Pieter; Hunink, M G Myriam (2012). Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Annals of thoracic surgery, 94(6), pp. 1954-60. New York, N.Y.: Elsevier 10.1016/j.athoracsur.2012.07.002

[img] Text
Osnabrugge AnnThoracSurg 2012.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (196kB) | Request a copy

Transcatheter aortic valve replacement (TAVR) offers a new treatment option for patients with aortic stenosis, but costs may play a decisive role in decision making. Current studies are evaluating TAVR in an intermediate-risk population. We assessed the in-hospital and 1-year follow-up costs of patients undergoing TAVR and surgical aortic valve replacement (SAVR) at intermediate operative risk and identified important cost components.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Kalesan, Bindu

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0003-4975

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:36

Last Modified:

15 Sep 2017 00:47

Publisher DOI:

10.1016/j.athoracsur.2012.07.002

PubMed ID:

22959568

Web of Science ID:

000311436300036

BORIS DOI:

10.7892/boris.14391

URI:

https://boris.unibe.ch/id/eprint/14391 (FactScience: 221358)

Actions (login required)

Edit item Edit item
Provide Feedback